ID   H3_KLULA                Reviewed;         136 AA.
AC   P61831; P02303; P13996; Q6CMU5; Q6CP01;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   22-JUL-2015, entry version 77.
DE   RecName: Full=Histone H3;
GN   Name=HHT1; OrderedLocusNames=KLLA0E08591g;
GN   and
GN   Name=HHT2; OrderedLocusNames=KLLA0E17677g;
OS   Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC
OS   1267 / NRRL Y-1140 / WM37) (Yeast) (Candida sphaerica).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Kluyveromyces.
OX   NCBI_TaxID=284590;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2538971; DOI=10.1002/yea.320050106;
RA   Stark M.J.R., Milner J.S.;
RT   "Cloning and analysis of the Kluyveromyces lactis TRP1 gene: a
RT   chromosomal locus flanked by genes encoding inorganic pyrophosphatase
RT   and histone H3.";
RL   Yeast 5:35-50(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 /
RC   WM37;
RX   PubMed=15229592; DOI=10.1038/nature02579;
RA   Dujon B., Sherman D., Fischer G., Durrens P., Casaregola S.,
RA   Lafontaine I., de Montigny J., Marck C., Neuveglise C., Talla E.,
RA   Goffard N., Frangeul L., Aigle M., Anthouard V., Babour A., Barbe V.,
RA   Barnay S., Blanchin S., Beckerich J.-M., Beyne E., Bleykasten C.,
RA   Boisrame A., Boyer J., Cattolico L., Confanioleri F., de Daruvar A.,
RA   Despons L., Fabre E., Fairhead C., Ferry-Dumazet H., Groppi A.,
RA   Hantraye F., Hennequin C., Jauniaux N., Joyet P., Kachouri R.,
RA   Kerrest A., Koszul R., Lemaire M., Lesur I., Ma L., Muller H.,
RA   Nicaud J.-M., Nikolski M., Oztas S., Ozier-Kalogeropoulos O.,
RA   Pellenz S., Potier S., Richard G.-F., Straub M.-L., Suleau A.,
RA   Swennen D., Tekaia F., Wesolowski-Louvel M., Westhof E., Wirth B.,
RA   Zeniou-Meyer M., Zivanovic Y., Bolotin-Fukuhara M., Thierry A.,
RA   Bouchier C., Caudron B., Scarpelli C., Gaillardin C., Weissenbach J.,
RA   Wincker P., Souciet J.-L.;
RT   "Genome evolution in yeasts.";
RL   Nature 430:35-44(2004).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and
CC       compact DNA into chromatin, limiting DNA accessibility to the
CC       cellular machineries which require DNA as a template. Histones
CC       thereby play a central role in transcription regulation, DNA
CC       repair, DNA replication and chromosomal stability. DNA
CC       accessibility is regulated via a complex set of post-translational
CC       modifications of histones, also called histone code, and
CC       nucleosome remodeling.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two
CC       molecules each of H2A, H2B, H3 and H4 assembled in one H3-H4
CC       heterotetramer and two H2A-H2B heterodimers. The octamer wraps
CC       approximately 147 bp of DNA.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylated by IPL1 to form H3S10ph. H3S10ph promotes
CC       subsequent H3K14ac formation by GCN5 and is required for
CC       transcriptional activation through TBP recruitment to the
CC       promoters (By similarity). {ECO:0000250}.
CC   -!- PTM: Mono-, di- and trimethylated by the COMPASS complex to form
CC       H3K4me1/2/3. H3K4me activates gene expression by regulating
CC       transcription elongation and plays a role in telomere length
CC       maintenance. H3K4me enrichment correlates with transcription
CC       levels, and occurs in a 5' to 3' gradient with H3K4me3 enrichment
CC       at the 5'-end of genes, shifting to H3K4me2 and then H3K4me1.
CC       Methylated by SET2 to form H3K36me. H3K36me represses gene
CC       expression. Methylated by DOT1 to form H3K79me. H3K79me is
CC       required for association of SIR proteins with telomeric regions
CC       and for telomeric silencing. The COMPASS-mediated formation of
CC       H3K4me2/3 and the DOT1-mediated formation of H3K79me require
CC       H2BK123ub1 (By similarity). {ECO:0000250}.
CC   -!- PTM: Acetylation of histone H3 leads to transcriptional
CC       activation. H3K14ac formation by GCN5 is promoted by H3S10ph.
CC       H3K14ac can also be formed by ESA1. H3K56ac formation occurs
CC       predominantly in newly synthesized H3 molecules during G1, S and
CC       G2/M of the cell cycle and may be involved in DNA repair (By
CC       similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the histone H3 family. {ECO:0000305}.
CC   -!- CAUTION: To ensure consistency between histone entries, we follow
CC       the 'Brno' nomenclature for histone modifications, with positions
CC       referring to those used in the literature for the 'closest' model
CC       organism. Due to slight variations in histone sequences between
CC       organisms and to the presence of initiator methionine in
CC       UniProtKB/Swiss-Prot sequences, the actual positions of modified
CC       amino acids in the sequence generally differ. In this entry the
CC       following conventions are used: H3K4me1/2/3 = mono-, di- and
CC       trimethylated Lys-5; H3K9ac = acetylated Lys-10; H3K9me1 =
CC       monomethylated Lys-10; H3S10ph = phosphorylated Ser-11; H3K14ac =
CC       acetylated Lys-15; H3K14me2 = dimethylated Lys-15; H3K18ac =
CC       acetylated Lys-19; H3K18me1 = monomethylated Lys-19; H3K23ac =
CC       acetylated Lys-24; H3K23me1 = monomethylated Lys-24; H3K27ac =
CC       acetylated Lys-28; H3K27me1/2/3 = mono-, di- and trimethylated
CC       Lys-28; H3K36ac = acetylated Lys-37; H3K36me1/2/3 = mono-, di- and
CC       trimethylated Lys-37; H3K56ac = acetylated Lys-57; H3K64ac =
CC       acetylated Lys-65; H3K79me1/2/3 = mono-, di- and trimethylated
CC       Lys-80. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAG99425.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X14230; CAA32444.1; -; Genomic_DNA.
DR   EMBL; CR382125; CAG99425.1; ALT_INIT; Genomic_DNA.
DR   EMBL; CR382125; CAG99831.1; -; Genomic_DNA.
DR   PIR; S07892; HSVK3L.
DR   RefSeq; XP_454744.1; XM_454744.1.
DR   PDB; 1PEG; X-ray; 2.59 A; P/Q=2-16.
DR   PDBsum; 1PEG; -.
DR   ProteinModelPortal; P61831; -.
DR   SMR; P61831; 2-136.
DR   STRING; 284590.XP_454338.1; -.
DR   GeneID; 2894116; -.
DR   KEGG; kla:KLLA0E17623g; -.
DR   eggNOG; COG2036; -.
DR   HOGENOM; HOG000155290; -.
DR   InParanoid; P61831; -.
DR   KO; K11253; -.
DR   OrthoDB; EOG7T4MZ6; -.
DR   Proteomes; UP000000598; Chromosome E.
DR   GO; GO:0000786; C:nucleosome; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_core_D.
DR   InterPro; IPR000164; Histone_H3/CENP-A.
DR   PANTHER; PTHR11426; PTHR11426; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00622; HISTONEH3.
DR   SMART; SM00428; H3; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00322; HISTONE_H3_1; 1.
DR   PROSITE; PS00959; HISTONE_H3_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosome; Complete proteome; DNA-binding;
KW   Methylation; Nucleosome core; Nucleus; Phosphoprotein;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000250}.
FT   CHAIN         2    136       Histone H3.
FT                                /FTId=PRO_0000221362.
FT   MOD_RES       5      5       N6,N6,N6-trimethyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES       5      5       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES       5      5       N6-methyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      10     10       N6-acetyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      10     10       N6-methyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      11     11       Phosphoserine. {ECO:0000250}.
FT   MOD_RES      15     15       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      15     15       N6-acetyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      15     15       N6-methyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      19     19       N6-acetyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      19     19       N6-methyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      24     24       N6-acetyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      24     24       N6-methyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      28     28       N6,N6,N6-trimethyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      28     28       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      28     28       N6-acetyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      28     28       N6-methyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      37     37       N6,N6,N6-trimethyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      37     37       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      37     37       N6-acetyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      37     37       N6-methyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      57     57       N6-acetyllysine. {ECO:0000250}.
FT   MOD_RES      65     65       N6-acetyllysine. {ECO:0000250}.
FT   MOD_RES      80     80       N6,N6,N6-trimethyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      80     80       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES      80     80       N6-methyllysine; alternate.
FT                                {ECO:0000250}.
SQ   SEQUENCE   136 AA;  15356 MW;  A6115FEB480AC67A CRC64;
     MARTKQTARK STGGKAPRKQ LASKAARKSA PSTGGVKKPH RYKPGTVALR EIRRFQKSTE
     LLIRKLPFQR LVREIAQDFK TDLRFQSSAI GALQESVEAY LVSLFEDTNL AAIHAKRVTI
     QKKDIKLARR LRGERS
//
ID   H3_YEAST                Reviewed;         136 AA.
AC   P61830; D6VQ11; E9PAG1; P02303; P13996; Q6B1U3; Q6Q7G9;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   22-JUL-2015, entry version 127.
DE   RecName: Full=Histone H3;
GN   Name=HHT1; OrderedLocusNames=YBR010W; ORFNames=YBR0201;
GN   and
GN   Name=HHT2; Synonyms=SIN2; OrderedLocusNames=YNL031C; ORFNames=N2749;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina;
OC   Saccharomycetes; Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6355483; DOI=10.1016/S0022-2836(83)80164-8;
RA   Smith M.M., Andresson O.S.;
RT   "DNA sequences of yeast H3 and H4 histone genes from two non-allelic
RT   gene sets encode identical H3 and H4 proteins.";
RL   J. Mol. Biol. 169:663-690(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (HHT1).
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=7813418;
RA   Feldmann H., Aigle M., Aljinovic G., Andre B., Baclet M.C., Barthe C.,
RA   Baur A., Becam A.-M., Biteau N., Boles E., Brandt T., Brendel M.,
RA   Brueckner M., Bussereau F., Christiansen C., Contreras R., Crouzet M.,
RA   Cziepluch C., Demolis N., Delaveau T., Doignon F., Domdey H.,
RA   Duesterhus S., Dubois E., Dujon B., El Bakkoury M., Entian K.-D.,
RA   Feuermann M., Fiers W., Fobo G.M., Fritz C., Gassenhuber J.,
RA   Glansdorff N., Goffeau A., Grivell L.A., de Haan M., Hein C.,
RA   Herbert C.J., Hollenberg C.P., Holmstroem K., Jacq C., Jacquet M.,
RA   Jauniaux J.-C., Jonniaux J.-L., Kallesoee T., Kiesau P., Kirchrath L.,
RA   Koetter P., Korol S., Liebl S., Logghe M., Lohan A.J.E., Louis E.J.,
RA   Li Z.Y., Maat M.J., Mallet L., Mannhaupt G., Messenguy F., Miosga T.,
RA   Molemans F., Mueller S., Nasr F., Obermaier B., Perea J., Pierard A.,
RA   Piravandi E., Pohl F.M., Pohl T.M., Potier S., Proft M., Purnelle B.,
RA   Ramezani Rad M., Rieger M., Rose M., Schaaff-Gerstenschlaeger I.,
RA   Scherens B., Schwarzlose C., Skala J., Slonimski P.P., Smits P.H.M.,
RA   Souciet J.-L., Steensma H.Y., Stucka R., Urrestarazu L.A.,
RA   van der Aart Q.J.M., Van Dyck L., Vassarotti A., Vetter I.,
RA   Vierendeels F., Vissers S., Wagner G., de Wergifosse P., Wolfe K.H.,
RA   Zagulski M., Zimmermann F.K., Mewes H.-W., Kleine K.;
RT   "Complete DNA sequence of yeast chromosome II.";
RL   EMBO J. 13:5795-5809(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (HHT2).
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169873;
RA   Philippsen P., Kleine K., Poehlmann R., Duesterhoeft A., Hamberg K.,
RA   Hegemann J.H., Obermaier B., Urrestarazu L.A., Aert R., Albermann K.,
RA   Altmann R., Andre B., Baladron V., Ballesta J.P.G., Becam A.-M.,
RA   Beinhauer J.D., Boskovic J., Buitrago M.J., Bussereau F., Coster F.,
RA   Crouzet M., D'Angelo M., Dal Pero F., De Antoni A., del Rey F.,
RA   Doignon F., Domdey H., Dubois E., Fiedler T.A., Fleig U., Floeth M.,
RA   Fritz C., Gaillardin C., Garcia-Cantalejo J.M., Glansdorff N.,
RA   Goffeau A., Gueldener U., Herbert C.J., Heumann K., Heuss-Neitzel D.,
RA   Hilbert H., Hinni K., Iraqui Houssaini I., Jacquet M., Jimenez A.,
RA   Jonniaux J.-L., Karpfinger-Hartl L., Lanfranchi G., Lepingle A.,
RA   Levesque H., Lyck R., Maftahi M., Mallet L., Maurer C.T.C.,
RA   Messenguy F., Mewes H.-W., Moestl D., Nasr F., Nicaud J.-M.,
RA   Niedenthal R.K., Pandolfo D., Pierard A., Piravandi E., Planta R.J.,
RA   Pohl T.M., Purnelle B., Rebischung C., Remacha M.A., Revuelta J.L.,
RA   Rinke M., Saiz J.E., Sartorello F., Scherens B., Sen-Gupta M.,
RA   Soler-Mira A., Urbanus J.H.M., Valle G., Van Dyck L., Verhasselt P.,
RA   Vierendeels F., Vissers S., Voet M., Volckaert G., Wach A.,
RA   Wambutt R., Wedler H., Zollner A., Hani J.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XIV
RT   and its evolutionary implications.";
RL   Nature 387:93-98(1997).
RN   [4]
RP   GENOME REANNOTATION (HHT1 AND HHT2).
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M.,
RA   Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and
RT   now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (HHT1 AND HHT2).
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=17322287; DOI=10.1101/gr.6037607;
RA   Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F.,
RA   Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A.,
RA   Raphael J., Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F.,
RA   Williamson J., Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G.,
RA   Kolodner R.D., LaBaer J.;
RT   "Approaching a complete repository of sequence-verified protein-
RT   encoding clones for Saccharomyces cerevisiae.";
RL   Genome Res. 17:536-543(2007).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-136.
RX   PubMed=7035169; DOI=10.1111/j.1432-1033.1982.tb05815.x;
RA   Brandt W.F., von Holt C.;
RT   "The primary structure of yeast histone H3.";
RL   Eur. J. Biochem. 121:501-510(1982).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-134.
RC   STRAIN=ATCC 204508 / S288c, M13, M14, M22, M32, M34, M5, M8, and
RC   YPS163;
RX   PubMed=15059259; DOI=10.1186/gb-2004-5-4-r26;
RA   Fay J.C., McCullough H.L., Sniegowski P.D., Eisen M.B.;
RT   "Population genetic variation in gene expression is associated with
RT   phenotypic variation in Saccharomyces cerevisiae.";
RL   Genome Biol. 5:R26.1-R26.14(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-16.
RX   PubMed=782914; DOI=10.1016/0014-5793(76)80153-6;
RA   Brandt W.F., von Holt C.;
RT   "The occurrence of histone H3 and H4 in yeast.";
RL   FEBS Lett. 65:386-390(1976).
RN   [9]
RP   PROTEIN SEQUENCE OF 28-41, AND ACETYLATION AT LYS-37.
RX   PubMed=17189264; DOI=10.1074/jbc.M607909200;
RA   Morris S.A., Rao B., Garcia B.A., Hake S.B., Diaz R.L.,
RA   Shabanowitz J., Hunt D.F., Allis C.D., Lieb J.D., Strahl B.D.;
RT   "Identification of histone H3 lysine 36 acetylation as a highly
RT   conserved histone modification.";
RL   J. Biol. Chem. 282:7632-7640(2007).
RN   [10]
RP   PROTEIN SEQUENCE OF 55-64, ACETYLATION AT LYS-57, AND MUTAGENESIS OF
RP   ARG-53; LYS-57; LYS-80 AND THR-119.
RX   PubMed=16260619; DOI=10.1128/MCB.25.22.10060-10070.2005;
RA   Hyland E.M., Cosgrove M.S., Molina H., Wang D., Pandey A.,
RA   Cottee R.J., Boeke J.D.;
RT   "Insights into the role of histone H3 and histone H4 core modifiable
RT   residues in Saccharomyces cerevisiae.";
RL   Mol. Cell. Biol. 25:10060-10070(2005).
RN   [11]
RP   IDENTIFICATION IN THE UAF COMPLEX.
RX   PubMed=9391047; DOI=10.1073/pnas.94.25.13458;
RA   Keener J., Dodd J.A., Lalo D., Nomura M.;
RT   "Histones H3 and H4 are components of upstream activation factor
RT   required for the high-level transcription of yeast rDNA by RNA
RT   polymerase I.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:13458-13462(1997).
RN   [12]
RP   ACETYLATION AT LYS-10; LYS-15 AND LYS-19.
RX   PubMed=9606197; DOI=10.1093/emboj/17.11.3155;
RA   Zhang W., Bone J.R., Edmondson D.G., Turner B.M., Roth S.Y.;
RT   "Essential and redundant functions of histone acetylation revealed by
RT   mutation of target lysines and loss of the Gcn5p acetyltransferase.";
RL   EMBO J. 17:3155-3167(1998).
RN   [13]
RP   ACETYLATION AT LYS-15.
RX   PubMed=10082517;
RA   Clarke A.S., Lowell J.E., Jacobson S.J., Pillus L.;
RT   "Esa1p is an essential histone acetyltransferase required for cell
RT   cycle progression.";
RL   Mol. Cell. Biol. 19:2515-2526(1999).
RN   [14]
RP   PHOSPHORYLATION AT SER-11 BY IPL1, DEPHOSPHORYLATION BY GLC7, AND
RP   MUTAGENESIS OF SER-11.
RX   PubMed=10975519; DOI=10.1016/S0092-8674(00)00034-9;
RA   Hsu J.-Y., Sun Z.-W., Li X., Reuben M., Tatchell K., Bishop D.K.,
RA   Grushcow J.M., Brame C.J., Caldwell J.A., Hunt D.F., Lin R.,
RA   Smith M.M., Allis C.D.;
RT   "Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora
RT   kinase and Glc7/PP1 phosphatase in budding yeast and nematodes.";
RL   Cell 102:279-291(2000).
RN   [15]
RP   ACETYLATION.
RX   PubMed=10777603; DOI=10.1074/jbc.275.17.13007;
RA   Waterborg J.H.;
RT   "Steady-state levels of histone acetylation in Saccharomyces
RT   cerevisiae.";
RL   J. Biol. Chem. 275:13007-13011(2000).
RN   [16]
RP   PHOSPHORYLATION AT SER-11, ACETYLATION AT LYS-15, AND MUTAGENESIS OF
RP   SER-11.
RX   PubMed=10911986; DOI=10.1016/S1097-2765(00)80257-9;
RA   Lo W.-S., Trievel R.C., Rojas J.R., Duggan L., Hsu J.-Y., Allis C.D.,
RA   Marmorstein R., Berger S.L.;
RT   "Phosphorylation of serine 10 in histone H3 is functionally linked in
RT   vitro and in vivo to Gcn5-mediated acetylation at lysine 14.";
RL   Mol. Cell 5:917-926(2000).
RN   [17]
RP   METHYLATION AT LYS-5.
RX   PubMed=11742990; DOI=10.1093/emboj/20.24.7137;
RA   Roguev A., Schaft D., Shevchenko A., Pijnappel W.W.M.P., Wilm M.,
RA   Aasland R., Stewart A.F.;
RT   "The Saccharomyces cerevisiae Set1 complex includes an Ash2 homologue
RT   and methylates histone 3 lysine 4.";
RL   EMBO J. 20:7137-7148(2001).
RN   [18]
RP   METHYLATION AT LYS-5.
RX   PubMed=11751634; DOI=10.1101/gad.940201;
RA   Briggs S.D., Bryk M., Strahl B.D., Cheung W.L., Davie J.K.,
RA   Dent S.Y.R., Winston F., Allis C.D.;
RT   "Histone H3 lysine 4 methylation is mediated by Set1 and required for
RT   cell growth and rDNA silencing in Saccharomyces cerevisiae.";
RL   Genes Dev. 15:3286-3295(2001).
RN   [19]
RP   ACETYLATION AT LYS-10; LYS-15; LYS-19; LYS-24 AND LYS-28.
RX   PubMed=11545749; DOI=10.1016/S1097-2765(01)00301-X;
RA   Suka N., Suka Y., Carmen A.A., Wu J., Grunstein M.;
RT   "Highly specific antibodies determine histone acetylation site usage
RT   in yeast heterochromatin and euchromatin.";
RL   Mol. Cell 8:473-479(2001).
RN   [20]
RP   METHYLATION AT LYS-80, AND MUTAGENESIS OF LYS-80.
RX   PubMed=12080090; DOI=10.1101/gad.1001502;
RA   Ng H.H., Feng Q., Wang H., Erdjument-Bromage H., Tempst P., Zhang Y.,
RA   Struhl K.;
RT   "Lysine methylation within the globular domain of histone H3 by Dot1
RT   is important for telomeric silencing and Sir protein association.";
RL   Genes Dev. 16:1518-1527(2002).
RN   [21]
RP   METHYLATION AT LYS-80.
RX   PubMed=12097318; DOI=10.1074/jbc.C200366200;
RA   Lacoste N., Utley R.T., Hunter J.M., Poirier G.G., Cote J.;
RT   "Disruptor of telomeric silencing-1 is a chromatin-specific histone H3
RT   methyltransferase.";
RL   J. Biol. Chem. 277:30421-30424(2002).
RN   [22]
RP   METHYLATION AT LYS-37.
RX   PubMed=11839797; DOI=10.1128/MCB.22.5.1298-1306.2002;
RA   Strahl B.D., Grant P.A., Briggs S.D., Sun Z.-W., Bone J.R.,
RA   Caldwell J.A., Mollah S., Cook R.G., Shabanowitz J., Hunt D.F.,
RA   Allis C.D.;
RT   "Set2 is a nucleosomal histone H3-selective methyltransferase that
RT   mediates transcriptional repression.";
RL   Mol. Cell. Biol. 22:1298-1306(2002).
RN   [23]
RP   METHYLATION AT LYS-5; LYS-37 AND LYS-80.
RX   PubMed=12152067; DOI=10.1038/nature00970;
RA   Briggs S.D., Xiao T., Sun Z.-W., Caldwell J.A., Shabanowitz J.,
RA   Hunt D.F., Allis C.D., Strahl B.D.;
RT   "Gene silencing: trans-histone regulatory pathway in chromatin.";
RL   Nature 418:498-498(2002).
RN   [24]
RP   METHYLATION AT LYS-5.
RX   PubMed=12353038; DOI=10.1038/nature01080;
RA   Santos-Rosa H., Schneider R., Bannister A.J., Sherriff J.,
RA   Bernstein B.E., Emre N.C.T., Schreiber S.L., Mellor J., Kouzarides T.;
RT   "Active genes are tri-methylated at K4 of histone H3.";
RL   Nature 419:407-411(2002).
RN   [25]
RP   METHYLATION AT LYS-5.
RX   PubMed=11752412; DOI=10.1073/pnas.221596698;
RA   Nagy P.L., Griesenbeck J., Kornberg R.D., Cleary M.L.;
RT   "A trithorax-group complex purified from Saccharomyces cerevisiae is
RT   required for methylation of histone H3.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:90-94(2002).
RN   [26]
RP   METHYLATION AT LYS-37.
RX   PubMed=12629047; DOI=10.1101/gad.1055503;
RA   Xiao T., Hall H., Kizer K.O., Shibata Y., Hall M.C., Borchers C.H.,
RA   Strahl B.D.;
RT   "Phosphorylation of RNA polymerase II CTD regulates H3 methylation in
RT   yeast.";
RL   Genes Dev. 17:654-663(2003).
RN   [27]
RP   METHYLATION AT LYS-37.
RX   PubMed=12773564; DOI=10.1128/MCB.23.12.4207-4218.2003;
RA   Krogan N.J., Kim M., Tong A., Golshani A., Cagney G., Canadien V.,
RA   Richards D.P., Beattie B.K., Emili A., Boone C., Shilatifard A.,
RA   Buratowski S., Greenblatt J.;
RT   "Methylation of histone H3 by Set2 in Saccharomyces cerevisiae is
RT   linked to transcriptional elongation by RNA polymerase II.";
RL   Mol. Cell. Biol. 23:4207-4218(2003).
RN   [28]
RP   METHYLATION AT LYS-37.
RX   PubMed=12917322; DOI=10.1128/MCB.23.17.5972-5978.2003;
RA   Landry J., Sutton A., Hesman T., Min J., Xu R.-M., Johnston M.,
RA   Sternglanz R.;
RT   "Set2-catalyzed methylation of histone H3 represses basal expression
RT   of GAL4 in Saccharomyces cerevisiae.";
RL   Mol. Cell. Biol. 23:5972-5978(2003).
RN   [29]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A.,
RA   Dephoure N., O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [30]
RP   METHYLATION AT LYS-80.
RX   PubMed=12574507; DOI=10.1073/pnas.0437846100;
RA   Ng H.H., Ciccone D.N., Morshead K.B., Oettinger M.A., Struhl K.;
RT   "Lysine-79 of histone H3 is hypomethylated at silenced loci in yeast
RT   and mammalian cells: a potential mechanism for position-effect
RT   variegation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:1820-1825(2003).
RN   [31]
RP   METHYLATION AT LYS-5, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=12845608; DOI=10.1002/yea.995;
RA   Boa S., Coert C., Patterton H.-G.;
RT   "Saccharomyces cerevisiae Set1p is a methyltransferase specific for
RT   lysine 4 of histone H3 and is required for efficient gene
RT   expression.";
RL   Yeast 20:827-835(2003).
RN   [32]
RP   PHOSPHORYLATION AT SER-11, AND ACETYLATION AT LYS-15.
RX   PubMed=15719021; DOI=10.1038/sj.emboj.7600577;
RA   Lo W.-S., Gamache E.R., Henry K.W., Yang D., Pillus L., Berger S.L.;
RT   "Histone H3 phosphorylation can promote TBP recruitment through
RT   distinct promoter-specific mechanisms.";
RL   EMBO J. 24:997-1008(2005).
RN   [33]
RP   METHYLATION AT LYS-80.
RX   PubMed=15632126; DOI=10.1074/jbc.M414453200;
RA   Giannattasio M., Lazzaro F., Plevani P., Muzi-Falconi M.;
RT   "The DNA damage checkpoint response requires histone H2B
RT   ubiquitination by Rad6-Bre1 and H3 methylation by Dot1.";
RL   J. Biol. Chem. 280:9879-9886(2005).
RN   [34]
RP   ACETYLATION AT LYS-57, AND MUTAGENESIS OF LYS-57.
RX   PubMed=15888442; DOI=10.1074/jbc.C500181200;
RA   Ozdemir A., Spicuglia S., Lasonder E., Vermeulen M., Campsteijn C.,
RA   Stunnenberg H.G., Logie C.;
RT   "Characterization of lysine 56 of histone H3 as an acetylation site in
RT   Saccharomyces cerevisiae.";
RL   J. Biol. Chem. 280:25949-25952(2005).
RN   [35]
RP   METHYLATION AT LYS-5.
RX   PubMed=16185711; DOI=10.1016/j.jmb.2005.08.059;
RA   Dehe P.-M., Pamblanco M., Luciano P., Lebrun R., Moinier D.,
RA   Sendra R., Verreault A., Tordera V., Geli V.;
RT   "Histone H3 lysine 4 mono-methylation does not require ubiquitination
RT   of histone H2B.";
RL   J. Mol. Biol. 353:477-484(2005).
RN   [36]
RP   METHYLATION AT LYS-5.
RX   PubMed=15949446; DOI=10.1016/j.molcel.2005.05.009;
RA   Morillon A., Karabetsou N., Nair A., Mellor J.;
RT   "Dynamic lysine methylation on histone H3 defines the regulatory phase
RT   of gene transcription.";
RL   Mol. Cell 18:723-734(2005).
RN   [37]
RP   METHYLATION AT LYS-5.
RX   PubMed=16168379; DOI=10.1016/j.molcel.2005.07.024;
RA   Schneider J., Wood A., Lee J.-S., Schuster R., Dueker J., Maguire C.,
RA   Swanson S.K., Florens L., Washburn M.P., Shilatifard A.;
RT   "Molecular regulation of histone H3 trimethylation by COMPASS and the
RT   regulation of gene expression.";
RL   Mol. Cell 19:849-856(2005).
RN   [38]
RP   METHYLATION AT LYS-37.
RX   PubMed=15798214; DOI=10.1128/MCB.25.8.3305-3316.2005;
RA   Kizer K.O., Phatnani H.P., Shibata Y., Hall H., Greenleaf A.L.,
RA   Strahl B.D.;
RT   "A novel domain in Set2 mediates RNA polymerase II interaction and
RT   couples histone H3 K36 methylation with transcript elongation.";
RL   Mol. Cell. Biol. 25:3305-3316(2005).
RN   [39]
RP   ACETYLATION AT LYS-57, MUTAGENESIS OF LYS-57, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=16015338; DOI=10.1038/nature03714;
RA   Masumoto H., Hawke D., Kobayashi R., Verreault A.;
RT   "A role for cell-cycle-regulated histone H3 lysine 56 acetylation in
RT   the DNA damage response.";
RL   Nature 436:294-298(2005).
RN   [40]
RP   METHYLATION AT LYS-5, AND ACETYLATION AT LYS-10; LYS-15 AND LYS-19.
RX   PubMed=16122352; DOI=10.1371/journal.pbio.0030328;
RA   Liu C.L., Kaplan T., Kim M., Buratowski S., Schreiber S.L.,
RA   Friedman N., Rando O.J.;
RT   "Single-nucleosome mapping of histone modifications in S.
RT   cerevisiae.";
RL   PLoS Biol. 3:1-17(2005).
RN   [41]
RP   ACETYLATION AT LYS-10; LYS-15; LYS-19; LYS-24; LYS-28; LYS-37; LYS-57
RP   AND LYS-65, METHYLATION AT LYS-5; LYS-10; LYS-15; LYS-19; LYS-24;
RP   LYS-28; LYS-37 AND LYS-80, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17194708; DOI=10.1074/jbc.M607900200;
RA   Garcia B.A., Hake S.B., Diaz R.L., Kauer M., Morris S.A., Recht J.,
RA   Shabanowitz J., Mishra N., Strahl B.D., Allis C.D., Hunt D.F.;
RT   "Organismal differences in post-translational modifications in
RT   histones H3 and H4.";
RL   J. Biol. Chem. 282:7641-7655(2007).
RN   [42]
RP   ACETYLATION AT LYS-57, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17320445; DOI=10.1016/j.molcel.2007.02.006;
RA   Tsubota T., Berndsen C.E., Erkmann J.A., Smith C.L., Yang L.,
RA   Freitas M.A., Denu J.M., Kaufman P.D.;
RT   "Histone H3-K56 acetylation is catalyzed by histone chaperone-
RT   dependent complexes.";
RL   Mol. Cell 25:703-712(2007).
RN   [43]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF H3 IN NUCLEOSOME COMPLEX.
RX   PubMed=11566884; DOI=10.1093/emboj/20.18.5207;
RA   White C.L., Suto R.K., Luger K.;
RT   "Structure of the yeast nucleosome core particle reveals fundamental
RT   changes in internucleosome interactions.";
RL   EMBO J. 20:5207-5218(2001).
CC   -!- FUNCTION: Core component of nucleosome. Nucleosomes wrap and
CC       compact DNA into chromatin, limiting DNA accessibility to the
CC       cellular machineries which require DNA as a template. Histones
CC       thereby play a central role in transcription regulation, DNA
CC       repair, DNA replication and chromosomal stability. DNA
CC       accessibility is regulated via a complex set of post-translational
CC       modifications of histones, also called histone code, and
CC       nucleosome remodeling. Component of the UAF (upstream activation
CC       factor) complex which interacts with the upstream element of the
CC       RNA polymerase I promoter and forms a stable preinitiation
CC       complex. Together with SPT15/TBP, UAF seems to stimulate basal
CC       transcription to a fully activated level.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two
CC       molecules each of H2A, H2B, H3 and H4 assembled in one H3-H4
CC       heterotetramer and two H2A-H2B heterodimers. The octamer wraps
CC       approximately 147 bp of DNA. Histone H3 is a component of the UAF
CC       (upstream activation factor) complex, which consists of UAF30,
CC       RRN5, RRN9, RRN10, and histones H3 and H4.
CC       {ECO:0000269|PubMed:9391047}.
CC   -!- INTERACTION:
CC       P32447:ASF1; NbExp=4; IntAct=EBI-8098, EBI-3003;
CC       P35817:BDF1; NbExp=2; IntAct=EBI-8098, EBI-3493;
CC       Q06205:FPR4; NbExp=5; IntAct=EBI-8098, EBI-6956;
CC       P02309:HHF2; NbExp=7; IntAct=EBI-8098, EBI-8113;
CC       P53096:HOS2; NbExp=2; IntAct=EBI-8098, EBI-8475;
CC       P36124:SET3; NbExp=2; IntAct=EBI-8098, EBI-16993;
CC       P32597:STH1; NbExp=4; IntAct=EBI-8098, EBI-18410;
CC       Q08465:YNG1; NbExp=5; IntAct=EBI-8098, EBI-31890;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome.
CC   -!- PTM: Phosphorylated by IPL1 to form H3S10ph in a cell cycle-
CC       dependent manner during mitosis and meiosis. H3S10ph is also
CC       formed by SNF1, promotes subsequent H3K14ac formation by GCN5, and
CC       is required for transcriptional activation through TBP recruitment
CC       to the promoters. Dephosphorylation is performed by GLC7.
CC       {ECO:0000269|PubMed:10911986, ECO:0000269|PubMed:10975519,
CC       ECO:0000269|PubMed:15719021}.
CC   -!- PTM: Mono-, di- and trimethylated by the COMPASS complex to form
CC       H3K4me1/2/3. H3K4me activates gene expression by regulating
CC       transcription elongation and plays a role in telomere length
CC       maintenance. H3K4me enrichment correlates with transcription
CC       levels, and occurs in a 5' to 3' gradient with H3K4me3 enrichment
CC       at the 5'-end of genes, shifting to H3K4me2 and then H3K4me1.
CC       Methylated by SET2 to form H3K36me. H3K36me represses gene
CC       expression. Methylated by DOT1 to form H3K79me. H3K79me is
CC       required for association of SIR proteins with telomeric regions
CC       and for telomeric silencing. The COMPASS-mediated formation of
CC       H3K4me2/3 and the DOT1-mediated formation of H3K79me require
CC       H2BK123ub1. {ECO:0000269|PubMed:11742990,
CC       ECO:0000269|PubMed:11751634, ECO:0000269|PubMed:11752412,
CC       ECO:0000269|PubMed:11839797, ECO:0000269|PubMed:12080090,
CC       ECO:0000269|PubMed:12097318, ECO:0000269|PubMed:12152067,
CC       ECO:0000269|PubMed:12353038, ECO:0000269|PubMed:12574507,
CC       ECO:0000269|PubMed:12629047, ECO:0000269|PubMed:12773564,
CC       ECO:0000269|PubMed:12845608, ECO:0000269|PubMed:12917322,
CC       ECO:0000269|PubMed:15632126, ECO:0000269|PubMed:15798214,
CC       ECO:0000269|PubMed:15949446, ECO:0000269|PubMed:16122352,
CC       ECO:0000269|PubMed:16168379, ECO:0000269|PubMed:16185711,
CC       ECO:0000269|PubMed:17194708}.
CC   -!- PTM: Acetylation of histone H3 leads to transcriptional
CC       activation. H3K14ac formation by GCN5, a component of the SAGA
CC       complex, is promoted by H3S10ph. Further acetylated by GCN5 to
CC       form H3K9ac, H3K18ac, H3K23ac, H3K27ac and H3K36ac. H3K14ac can
CC       also be formed by ESA1, a component of the NuA4 histone
CC       acetyltransferase (HAT) complex. H3K56ac formation occurs
CC       predominantly in newly synthesized H3 molecules during G1, S and
CC       G2/M of the cell cycle and may be involved in DNA repair.
CC       {ECO:0000269|PubMed:10082517, ECO:0000269|PubMed:10777603,
CC       ECO:0000269|PubMed:10911986, ECO:0000269|PubMed:11545749,
CC       ECO:0000269|PubMed:15719021, ECO:0000269|PubMed:15888442,
CC       ECO:0000269|PubMed:16015338, ECO:0000269|PubMed:16122352,
CC       ECO:0000269|PubMed:16260619, ECO:0000269|PubMed:17189264,
CC       ECO:0000269|PubMed:17194708, ECO:0000269|PubMed:17320445,
CC       ECO:0000269|PubMed:9606197}.
CC   -!- MISCELLANEOUS: Present with 213000 molecules/cell in log phase SD
CC       medium. {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the histone H3 family. {ECO:0000305}.
CC   -!- CAUTION: To ensure consistency between histone entries, we follow
CC       the 'Brno' nomenclature for histone modifications, with positions
CC       referring to those used in the literature for the 'closest' model
CC       organism. Due to slight variations in histone sequences between
CC       organisms and to the presence of initiator methionine in
CC       UniProtKB/Swiss-Prot sequences, the actual positions of modified
CC       amino acids in the sequence generally differ. In this entry the
CC       following conventions are used: H3K4me1/2/3 = mono-, di- and
CC       trimethylated Lys-5; H3K9ac = acetylated Lys-10; H3K9me1 =
CC       monomethylated Lys-10; H3S10ph = phosphorylated Ser-11; H3K14ac =
CC       acetylated Lys-15; H3K14me2 = dimethylated Lys-15; H3K18ac =
CC       acetylated Lys-19; H3K18me1 = monomethylated Lys-19; H3K23ac =
CC       acetylated Lys-24; H3K23me1 = monomethylated Lys-24; H3K27ac =
CC       acetylated Lys-28; H3K27me1/2/3 = mono-, di- and trimethylated
CC       Lys-28; H3K36ac = acetylated Lys-37; H3K36me1/2/3 = mono-, di- and
CC       trimethylated Lys-37; H3K56ac = acetylated Lys-57; H3K64ac =
CC       acetylated Lys-65; H3K79me1/2/3 = mono-, di- and trimethylated
CC       Lys-80. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X00724; CAA25310.1; -; Genomic_DNA.
DR   EMBL; X00725; CAA25312.1; -; Genomic_DNA.
DR   EMBL; Z35879; CAA84948.1; -; Genomic_DNA.
DR   EMBL; Z71306; CAA95893.1; -; Genomic_DNA.
DR   EMBL; Z71307; CAA95894.1; -; Genomic_DNA.
DR   EMBL; AY558343; AAS56669.1; -; Genomic_DNA.
DR   EMBL; AY692987; AAT93006.1; -; Genomic_DNA.
DR   EMBL; AY554000; AAS64341.1; -; Genomic_DNA.
DR   EMBL; AY554001; AAS64342.1; -; Genomic_DNA.
DR   EMBL; AY554002; AAS64343.1; -; Genomic_DNA.
DR   EMBL; AY554003; AAS64344.1; -; Genomic_DNA.
DR   EMBL; AY554004; AAS64345.1; -; Genomic_DNA.
DR   EMBL; AY554005; AAS64346.1; -; Genomic_DNA.
DR   EMBL; AY554006; AAS64347.1; -; Genomic_DNA.
DR   EMBL; AY554007; AAS64348.1; -; Genomic_DNA.
DR   EMBL; AY554008; AAS64349.1; -; Genomic_DNA.
DR   EMBL; BK006936; DAA07131.1; -; Genomic_DNA.
DR   EMBL; BK006947; DAA10514.1; -; Genomic_DNA.
DR   PIR; S45265; HSBY3.
DR   RefSeq; NP_009564.1; NM_001178358.1.
DR   RefSeq; NP_014367.1; NM_001182870.1.
DR   PDB; 1ID3; X-ray; 3.10 A; A/E=2-136.
DR   PDB; 1M1D; X-ray; 2.20 A; B/D=2-21.
DR   PDB; 1PU9; X-ray; 2.30 A; B=6-24.
DR   PDB; 1PUA; X-ray; 2.30 A; B=6-24.
DR   PDB; 1QSN; X-ray; 2.20 A; B=10-20.
DR   PDB; 2CNX; X-ray; 2.10 A; P=2-6.
DR   PDB; 2H2G; X-ray; 1.63 A; B=114-124.
DR   PDB; 2IDC; X-ray; 2.20 A; A=119-135.
DR   PDB; 2JMJ; NMR; -; P=2-10.
DR   PDB; 2RNW; NMR; -; B=2-16.
DR   PDB; 2RNX; NMR; -; B=32-43.
DR   PDB; 2RSN; NMR; -; B=2-18.
DR   PDB; 3MP1; X-ray; 2.60 A; P=2-6.
DR   PDB; 3MP6; X-ray; 1.48 A; P=2-5.
DR   PDB; 3Q33; X-ray; 2.80 A; D=2-15.
DR   PDB; 4JJN; X-ray; 3.09 A; A/E=2-136.
DR   PDB; 4KUD; X-ray; 3.20 A; A/E=1-136.
DR   PDB; 4PSX; X-ray; 2.51 A; P/Y=2-16.
DR   PDBsum; 1ID3; -.
DR   PDBsum; 1M1D; -.
DR   PDBsum; 1PU9; -.
DR   PDBsum; 1PUA; -.
DR   PDBsum; 1QSN; -.
DR   PDBsum; 2CNX; -.
DR   PDBsum; 2H2G; -.
DR   PDBsum; 2IDC; -.
DR   PDBsum; 2JMJ; -.
DR   PDBsum; 2RNW; -.
DR   PDBsum; 2RNX; -.
DR   PDBsum; 2RSN; -.
DR   PDBsum; 3MP1; -.
DR   PDBsum; 3MP6; -.
DR   PDBsum; 3Q33; -.
DR   PDBsum; 4JJN; -.
DR   PDBsum; 4KUD; -.
DR   PDBsum; 4PSX; -.
DR   ProteinModelPortal; P61830; -.
DR   SMR; P61830; 2-136.
DR   BioGrid; 32711; 713.
DR   BioGrid; 35796; 641.
DR   DIP; DIP-417N; -.
DR   IntAct; P61830; 145.
DR   MINT; MINT-702778; -.
DR   MaxQB; P61830; -.
DR   PaxDb; P61830; -.
DR   EnsemblFungi; YBR010W; YBR010W; YBR010W.
DR   EnsemblFungi; YNL031C; YNL031C; YNL031C.
DR   GeneID; 852295; -.
DR   GeneID; 855700; -.
DR   KEGG; sce:YBR010W; -.
DR   KEGG; sce:YNL031C; -.
DR   SGD; S000000214; HHT1.
DR   SGD; S000004976; HHT2.
DR   eggNOG; COG2036; -.
DR   GeneTree; ENSGT00730000110760; -.
DR   InParanoid; P61830; -.
DR   KO; K11253; -.
DR   OMA; CHASMAR; -.
DR   OrthoDB; EOG7T4MZ6; -.
DR   BioCyc; YEAST:G3O-28997-MONOMER; -.
DR   BioCyc; YEAST:G3O-33068-MONOMER; -.
DR   EvolutionaryTrace; P61830; -.
DR   NextBio; 970949; -.
DR   PRO; PR:P61830; -.
DR   Proteomes; UP000002311; Chromosome II.
DR   Proteomes; UP000002311; Chromosome XIV.
DR   GO; GO:0043505; C:CENP-A containing nucleosome; IDA:SGD.
DR   GO; GO:0000788; C:nuclear nucleosome; TAS:SGD.
DR   GO; GO:0031298; C:replication fork protection complex; IDA:SGD.
DR   GO; GO:0003677; F:DNA binding; TAS:SGD.
DR   GO; GO:0006333; P:chromatin assembly or disassembly; TAS:SGD.
DR   GO; GO:0070911; P:global genome nucleotide-excision repair; IMP:SGD.
DR   GO; GO:0009303; P:rRNA transcription; IMP:SGD.
DR   GO; GO:0043935; P:sexual sporulation resulting in formation of a cellular spore; IMP:SGD.
DR   Gene3D; 1.10.20.10; -; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_core_D.
DR   InterPro; IPR000164; Histone_H3/CENP-A.
DR   PANTHER; PTHR11426; PTHR11426; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00622; HISTONEH3.
DR   SMART; SM00428; H3; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
DR   PROSITE; PS00322; HISTONE_H3_1; 1.
DR   PROSITE; PS00959; HISTONE_H3_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosome; Complete proteome;
KW   Direct protein sequencing; DNA-binding; Methylation; Nucleosome core;
KW   Nucleus; Phosphoprotein; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:7035169,
FT                                ECO:0000269|PubMed:782914}.
FT   CHAIN         2    136       Histone H3.
FT                                /FTId=PRO_0000221370.
FT   MOD_RES       5      5       N6,N6,N6-trimethyllysine; alternate.
FT                                {ECO:0000269|PubMed:11742990,
FT                                ECO:0000269|PubMed:11751634,
FT                                ECO:0000269|PubMed:11752412,
FT                                ECO:0000269|PubMed:12152067,
FT                                ECO:0000269|PubMed:12353038,
FT                                ECO:0000269|PubMed:12845608,
FT                                ECO:0000269|PubMed:15949446,
FT                                ECO:0000269|PubMed:16122352,
FT                                ECO:0000269|PubMed:16168379,
FT                                ECO:0000269|PubMed:16185711,
FT                                ECO:0000269|PubMed:17194708}.
FT   MOD_RES       5      5       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000269|PubMed:11742990,
FT                                ECO:0000269|PubMed:11751634,
FT                                ECO:0000269|PubMed:11752412,
FT                                ECO:0000269|PubMed:12152067,
FT                                ECO:0000269|PubMed:12353038,
FT                                ECO:0000269|PubMed:12845608,
FT                                ECO:0000269|PubMed:15949446,
FT                                ECO:0000269|PubMed:16122352,
FT                                ECO:0000269|PubMed:16168379,
FT                                ECO:0000269|PubMed:16185711,
FT                                ECO:0000269|PubMed:17194708}.
FT   MOD_RES       5      5       N6-methyllysine; alternate.
FT                                {ECO:0000269|PubMed:11742990,
FT                                ECO:0000269|PubMed:11751634,
FT                                ECO:0000269|PubMed:11752412,
FT                                ECO:0000269|PubMed:12152067,
FT                                ECO:0000269|PubMed:12353038,
FT                                ECO:0000269|PubMed:12845608,
FT                                ECO:0000269|PubMed:15949446,
FT                                ECO:0000269|PubMed:16122352,
FT                                ECO:0000269|PubMed:16168379,
FT                                ECO:0000269|PubMed:16185711,
FT                                ECO:0000269|PubMed:17194708}.
FT   MOD_RES      10     10       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:11545749,
FT                                ECO:0000269|PubMed:16122352,
FT                                ECO:0000269|PubMed:17194708,
FT                                ECO:0000269|PubMed:9606197}.
FT   MOD_RES      10     10       N6-methyllysine; alternate.
FT                                {ECO:0000269|PubMed:17194708}.
FT   MOD_RES      11     11       Phosphoserine.
FT                                {ECO:0000269|PubMed:10911986,
FT                                ECO:0000269|PubMed:10975519,
FT                                ECO:0000269|PubMed:15719021}.
FT   MOD_RES      15     15       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000269|PubMed:17194708}.
FT   MOD_RES      15     15       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:10082517,
FT                                ECO:0000269|PubMed:10911986,
FT                                ECO:0000269|PubMed:11545749,
FT                                ECO:0000269|PubMed:15719021,
FT                                ECO:0000269|PubMed:16122352,
FT                                ECO:0000269|PubMed:17194708,
FT                                ECO:0000269|PubMed:9606197}.
FT   MOD_RES      19     19       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:11545749,
FT                                ECO:0000269|PubMed:16122352,
FT                                ECO:0000269|PubMed:17194708,
FT                                ECO:0000269|PubMed:9606197}.
FT   MOD_RES      19     19       N6-methyllysine; alternate.
FT                                {ECO:0000269|PubMed:17194708}.
FT   MOD_RES      24     24       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:11545749,
FT                                ECO:0000269|PubMed:17194708}.
FT   MOD_RES      24     24       N6-methyllysine; alternate.
FT                                {ECO:0000269|PubMed:17194708}.
FT   MOD_RES      28     28       N6,N6,N6-trimethyllysine; alternate.
FT                                {ECO:0000269|PubMed:17194708}.
FT   MOD_RES      28     28       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000269|PubMed:17194708}.
FT   MOD_RES      28     28       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:11545749,
FT                                ECO:0000269|PubMed:17194708}.
FT   MOD_RES      28     28       N6-methyllysine; alternate.
FT                                {ECO:0000269|PubMed:17194708}.
FT   MOD_RES      37     37       N6,N6,N6-trimethyllysine; alternate.
FT                                {ECO:0000269|PubMed:11839797,
FT                                ECO:0000269|PubMed:12152067,
FT                                ECO:0000269|PubMed:12629047,
FT                                ECO:0000269|PubMed:12773564,
FT                                ECO:0000269|PubMed:12917322,
FT                                ECO:0000269|PubMed:15798214,
FT                                ECO:0000269|PubMed:17194708}.
FT   MOD_RES      37     37       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000269|PubMed:11839797,
FT                                ECO:0000269|PubMed:12152067,
FT                                ECO:0000269|PubMed:12629047,
FT                                ECO:0000269|PubMed:12773564,
FT                                ECO:0000269|PubMed:12917322,
FT                                ECO:0000269|PubMed:15798214,
FT                                ECO:0000269|PubMed:17194708}.
FT   MOD_RES      37     37       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:17189264,
FT                                ECO:0000269|PubMed:17194708}.
FT   MOD_RES      37     37       N6-methyllysine; alternate.
FT                                {ECO:0000269|PubMed:11839797,
FT                                ECO:0000269|PubMed:12152067,
FT                                ECO:0000269|PubMed:12629047,
FT                                ECO:0000269|PubMed:12773564,
FT                                ECO:0000269|PubMed:12917322,
FT                                ECO:0000269|PubMed:15798214,
FT                                ECO:0000269|PubMed:17194708}.
FT   MOD_RES      57     57       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:15888442,
FT                                ECO:0000269|PubMed:16015338,
FT                                ECO:0000269|PubMed:16260619,
FT                                ECO:0000269|PubMed:17194708,
FT                                ECO:0000269|PubMed:17320445}.
FT   MOD_RES      65     65       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:17194708}.
FT   MOD_RES      80     80       N6,N6,N6-trimethyllysine; alternate.
FT                                {ECO:0000269|PubMed:12080090,
FT                                ECO:0000269|PubMed:12097318,
FT                                ECO:0000269|PubMed:12152067,
FT                                ECO:0000269|PubMed:12574507,
FT                                ECO:0000269|PubMed:15632126,
FT                                ECO:0000269|PubMed:17194708}.
FT   MOD_RES      80     80       N6,N6-dimethyllysine; alternate.
FT                                {ECO:0000269|PubMed:12080090,
FT                                ECO:0000269|PubMed:12097318,
FT                                ECO:0000269|PubMed:12152067,
FT                                ECO:0000269|PubMed:12574507,
FT                                ECO:0000269|PubMed:15632126,
FT                                ECO:0000269|PubMed:17194708}.
FT   MOD_RES      80     80       N6-methyllysine; alternate.
FT                                {ECO:0000269|PubMed:12080090,
FT                                ECO:0000269|PubMed:12097318,
FT                                ECO:0000269|PubMed:12152067,
FT                                ECO:0000269|PubMed:12574507,
FT                                ECO:0000269|PubMed:15632126,
FT                                ECO:0000269|PubMed:17194708}.
FT   MUTAGEN      11     11       S->A: Impairs histone H3 phosphorylation
FT                                and reduces transcription of some GCN5
FT                                regulated genes.
FT                                {ECO:0000269|PubMed:10911986,
FT                                ECO:0000269|PubMed:10975519}.
FT   MUTAGEN      53     53       R->A,K,Q: Lethal.
FT                                {ECO:0000269|PubMed:16260619}.
FT   MUTAGEN      57     57       K->A,Q,R: Increases sensitivity to
FT                                genotoxic agents inducing DNA breaks
FT                                during replication.
FT                                {ECO:0000269|PubMed:15888442,
FT                                ECO:0000269|PubMed:16015338,
FT                                ECO:0000269|PubMed:16260619}.
FT   MUTAGEN      80     80       K->A,P,Q: Compromises telomeric
FT                                silencing. {ECO:0000269|PubMed:12080090,
FT                                ECO:0000269|PubMed:16260619}.
FT   MUTAGEN     119    119       T->A,E: Lethal.
FT                                {ECO:0000269|PubMed:16260619}.
FT   CONFLICT    124    124       D -> E (in Ref. 6; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND        6      8       {ECO:0000244|PDB:2RSN}.
FT   STRAND       11     13       {ECO:0000244|PDB:2RNW}.
FT   HELIX        46     55       {ECO:0000244|PDB:4JJN}.
FT   HELIX        66     77       {ECO:0000244|PDB:4JJN}.
FT   HELIX        87    114       {ECO:0000244|PDB:4JJN}.
FT   STRAND      118    120       {ECO:0000244|PDB:4JJN}.
FT   HELIX       124    131       {ECO:0000244|PDB:2IDC}.
SQ   SEQUENCE   136 AA;  15356 MW;  A6115FEB480AC67A CRC64;
     MARTKQTARK STGGKAPRKQ LASKAARKSA PSTGGVKKPH RYKPGTVALR EIRRFQKSTE
     LLIRKLPFQR LVREIAQDFK TDLRFQSSAI GALQESVEAY LVSLFEDTNL AAIHAKRVTI
     QKKDIKLARR LRGERS
//
